Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2025
Impact of the Mucin Barrier on the In Vitro Membrane Permeability of Cyclic PeptidesYuji Sakurai, Kazuhisa Ozeki, Haruka Tsutsui, et al.Chemical & Pharmaceutical Bulletin|November 3, 2016
Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD)Terushige Muraoka, Mitsuaki Ide, Machiko Irie, et al.Bioorganic & Medicinal Chemistry Letters|November 15, 2011
Conformationally restricted analog and biotin-labeled probe based on beauveriolide IIITakayuki Doi, Terushige Muraoka, Taichi Ohshiro, et al.Bioorganic & Medicinal Chemistry Letters|January 23, 2017
Identification of a selective inhibitor of transforming growth factor β-activated kinase 1 by biosensor-based screening of focused librariesTakaaki Miura, Atsushi Matsuo, Terushige Muraoka, et al.Bioorganic & Medicinal Chemistry|July 25, 2016
Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)Terushige Muraoka, Mitsuaki Ide, Kenji Morikami, et al.Journal of Medicinal Chemistry|September 16, 2022
Broadly Applicable and Comprehensive Synthetic Method for <i>N</i>-Alkyl-Rich Drug-like Cyclic PeptidesKenichi Nomura, Satoshi Hashimoto, Ryuuichi Takeyama, et al.Cell Reports|December 28, 2020
Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor MicroenvironmentFuta Mimoto, Kanako Tatsumi, Shun Shimizu, et al.Journal of the American Chemical Society|October 24, 2023
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough TargetsAtsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.Pageof 1